VIRALYTICS LTD has a total of 51 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2000. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are CELLIS SP Z O O [LTD ], COFFEY MATTHEW C and STEM CELL THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 12 | |
#2 | United States | 12 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | Hong Kong | 3 | |
#7 | Japan | 3 | |
#8 | Republic of Korea | 2 | |
#9 | Singapore | 2 | |
#10 | South Africa | 2 | |
#11 | New Zealand | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Electrotherapy | |
#8 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Shafren Darren | 17 |
#2 | Au Gough Geoffrey | 15 |
#3 | Shafren Darren R | 13 |
#4 | Shafren Darren Raymond | 12 |
#5 | Au Gough | 5 |
#6 | Simpson Guy | 5 |
#7 | Pandha Hardev | 5 |
#8 | Geoffrey Au Gough | 4 |
#9 | Raymond Shafren Darren | 4 |
#10 | Shafren Raymond Darren | 3 |
Publication | Filing date | Title |
---|---|---|
CA2940570A1 | Combination method for treatment of cancer | |
US2016136211A1 | Methods for the treatment of bladder cancer | |
AU2011204997A1 | A method of treating a malignancy in a subject and a pharmaceutical composition for use in same | |
AU2007211890A1 | A method of treating a malignancy in a subject and a pharmaceutical composition for use in same | |
US2008160031A1 | Method and Composition for Treatment of Neoplasms | |
AU2006206053A1 | Method and composition for treatment of neoplasms | |
CN101065144A | Methods and compositions for treatment of hematologic cancers | |
AU2005274617A1 | Methods and compositions for treatment of hematologic cancers | |
KR20070083578A | Methods and compositions for treatment of hematologic cancers | |
AU2003287773A1 | A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |